Stent containing rapamycin or its analogs using a modified stent
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 26, 2004
Grant Date -
Sep 18, 2003
app pub date -
Apr 7, 2003
filing date -
Apr 18, 1997
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Delivery of rapamycin locally, particularly from an intravascular stent, directly from micropores in the stent body or mixed or bound to a polymer coating applied on stent, to inhibit neointimal tissue proliferation and thereby prevent restenosis. This invention also facilitates the performance of the stent in inhibiting restenosis.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully